Demo

10865 Articles Matching "drug"

Failed Alzheimer's trial leaves families and patients heartbroken. Medical community reels

Mar 24, 2019 , CNBC Health
Biogen and Eisai lost billions of dollars in market value after halting two late-stage trials of a promising experimental Alzheimer's...
Read more

Silicon Valley techies are turning to a cheap diabetes drug to help them live longer

Mar 24, 2019 , CNBC Health
Doctors feel that taking metformin is mostly safe, but cautioned about the lack of clinical...
Read more

How a premature ejaculation drug sparked a $150 million legal battle over trade secrets

Mar 24, 2019 , CNBC Health
The maker of the premature ejaculation drug Promescent is suing consumer giant Reckitt Benckiser for $150 million, alleging fraud and theft of trade...
Read more

Most popular health apps routinely share data with little transparency

Mar 23, 2019 dave.muoio@himssmedia.com (Dave Muoio), Mobile Health News
Researchers noted transmissions of specific sensitive data, such as a user’s drug list, that could de-identify the user and be repurposed for commercial...
Read more

Snap to drug advertisers: We're the friendlier social network

Mar 23, 2019 , CNBC Health
To win big pharmaceutical advertisers, Snap is positioning itself as a friendlier social network than Facebook and...
Read more
Demo

10 startups tackling the problem of high prescription drug costs

Mar 23, 2019 , Mobile Health News
Whether by managing payments, connecting consumers to reimbursement options or just manufacturing cheap drugs themselves, these companies are taking aim at a problem that's building to a...
Read more

FDA rejects Sanofi-Lexicon add-on pill for type 1 diabetes

Mar 23, 2019 , Reuters
The U.S. Food and Drug Administration declined to approve a drug developed by Sanofi SA and Lexicon Pharmaceuticals Inc intended for use with insulin in patients with type 1 diabetes, the companies said on Friday....
Read more

Biogen stock plunge shows 'investment model in drug development is all wrong,' says former Aetna CEO

Mar 23, 2019 , CNBC Health
Former Aetna Chairman and CEO Mark Bertolini says investors currently are trading "on a basis that says, 'does this drug work today? Did this trial pass...
Read more

Eisai starts trials for a second Alzheimer's drug a day after Biogen failure wiped $18B off its value

Mar 23, 2019 , CNBC Health
Eisai said it has begun phase 3 clinical trials of Alzheimer's treatment, a day after the Japanese drugmaker and U.S. partner Biogen scrapped trials for its own Alzheimer's...
Read more

Drug Combo Does Double Duty Against Common Skin Lesions, Cancers

Mar 23, 2019 , MedicineNet
Title: Drug Combo Does Double Duty Against Common Skin Lesions, CancersCategory: Health NewsCreated: 3/21/2019 12:00:00 AMLast Editorial Review: 3/21/2019 12:00:00...
Read more

Eisai starts phase 3 trials for second Alzheimer's drug after first's failure

Mar 23, 2019 , Reuters
Eisai Co Ltd on Friday said it has begun phase 3 clinical trials of Alzheimer's treatment BAN2401, a day after the Japanese drugmaker and U.S. partner Biogen Inc scrapped trials for another Alzheimer's drug, aducanumab....
Read more
Cardon Children's Medical Center

Improving TB Treatment—And Survival—In The World's Poorest Places

Mar 23, 2019 , NewsLine - Healthcare Professionals
Blood-test results remain a gold standard of accuracy when doctors need to determine if tuberculosis (TB) patients are adequately absorbing their medications. Indicators such as the blood levels of TB drugs at fixed timepoints after dosing, usually two and six hours, influence how treatment regimens......
Read more

Common Drug Combo Found to Cut Skin Cancer Odds

Mar 23, 2019 , WebMD
A two-ointment combo used to clear crusty skin growths known as actinic keratosis also has been found to greatly reduce the odds for squamous cell carcinomas (SCCs), the second most common form of skin...
Read more

How Will The Failure Of Biogen's Alzheimer's Drug, Aducanumab, Impact R&D?

Mar 23, 2019 , Forbes
The death of an important drug like aducanumab will have both a short and a long term effect on Biogen as a company and especially on...
Read more

J&J to record $700 million charge related to abandoned drug program

Mar 22, 2019 , Reuters
Johnson & Johnson on Thursday said it will record a nearly $700 million impairment charge in the first quarter of 2019 related to the abandoned development of its experimental antiviral drug, AL-8176....
Read more

Roche sues U.S. executives in fight over diabetes test strips

Mar 22, 2019 , Reuters
Roche is seeking damages and compensation in a U.S. lawsuit against former executives of a Utah-based company, the Swiss drugmaker's latest case targeting what it calls fraudulent schemes involving its diabetes test strips....
Read more

CBD Products Now Available at CVS in 8 States

Mar 22, 2019 , WebMD
The products will be sold in store aisles, according to a CVS spokesman, who added that the drugstore chain is not selling any supplements or food additives containing...
Read more

Kentucky launches probe into drug overcharges by pharmacy benefit managers

Mar 22, 2019 , Reuters
Kentucky Attorney General Andy Beshear said on Thursday he had launched an investigation into allegations that pharmacy benefit managers (PBMs) had overcharged state health insurance programs for drugs and discriminated against independent pharmacies....
Read more

Myrbetriq vs. Ditropan

Mar 22, 2019 , RxList
Myrbetriq (mirabegron) and Ditropan (oxybutynin chloride) are used to treat overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency. Myrbetriq and Ditropan belong to different drug classes. Myrbetriq is a beta-3 adrenergic agonist and Ditropan is an antispasmodic and...
Read more

Promising Alzheimer's drug trial ends in failure

Mar 22, 2019 , CNN Health
A promising drug designed to remove proteins from the brains of Alzheimer's patients has been halted, dealing another blow to the ongoing search for treatment and a cure....
Read more